Complex [(^DIPePBDI)Ca]₂(C₆H₆), with a C₆H₆²⁻dianion bridging two Ca²⁺ions, reacts with benzene to yield [(^DIPePBDI)Ca]₂(biphenyl) with a bridging biphenyl²⁻dianion (^DIPePBDI=HC[C(Me)N‐DIPeP]₂; DIPeP=2,6‐CH(Et)₂‐phenyl). The biphenyl complex was also prepared by reacting [(^DIPePBDI)Ca]₂(C₆H₆) with biphenyl or by reduction of [(^DIPePBDI)CaI]₂with KC₈in presence of biphenyl. Benzene‐benzene coupling was also observed when the deep purple product of ball‐milling [(^DIPPBDI)CaI(THF)]₂with K/KI was extracted with benzene (DIPP=2,6‐CH(Me)₂‐phenyl) giving crystalline [(^DIPPBDI)Ca(THF)]₂(biphenyl) (52 % yield). Reduction of [(^DIPePBDI)SrI]₂with KC₈gave highly labile [(^DIPePBDI)Sr]₂(C₆H₆) as a black powder (61 % yield) which reacts rapidly and selectively with benzene to [(^DIPePBDI)Sr]₂(biphenyl). DFT calculations show that the most likely route for biphenyl formation is a pathway in which the C₆H₆²⁻dianion attacks neutral benzene. This is facilitated by metal‐benzene coordination.

A family of o, p- and N-functionalized dihydro-2H-benzo-1,3-oxazines was synthesized and characterized. In vitro antimicrobial activity of the new benzoxazines was assessed against pathogenic fungi and Gram-negative and Gram-positive bacteria. The screened compounds showed significant in vitro antimicrobial effect, but introduction of the bulky substituent in the ortho position of the aryl ring caused a loss of their antibacterial efficacy. Cytotoxic assay results revealed that a molecule containing long alkyl chain substituents offered a remarkable viability of mouse fibroblast cells. Additionally, the liquid nature of alkyl-chain-modified monomers and the high processing windows indicate their high application potential.

New heteroleptic zinc dimeric complexes bearing an aminophenolate ligand of a single-site initiator framework were synthesized and characterized by spectroscopic methods, X-ray analysis, and DFT calculations.